희귀질환 분야 계약 연구기관(CRO) 시장 보고서(2026년)

A rare disease contract research organization (CRO) is a specialized service provider that supports pharmaceutical and biotechnology firms in planning and conducting clinical research and trials focused on rare or orphan diseases. It offers dedicated expertise to manage challenges such as small patient populations and the complex nature of these medical conditions.

The primary service types of rare disease contract research organization (CRO) include drug development strategy, clinical trial management, patient recruitment and retention services, data management and biostatistics, regulatory affairs and consulting, pharmacovigilance services, medical writing and documentation, decentralized clinical trial services, and other service types. Drug development strategy refers to highly specialized advisory and planning solutions that assist in structuring and implementing clinical development pathways for rare diseases with strong precision and alignment to regulatory expectations. These services are applied across development stages including pre clinical, phase one, phase two, phase three, and phase four and are concentrated on therapeutic areas such as oncology, neurology, cardiovascular disorders, metabolic disorders, genetic disorders, hematology, immunology, rare infectious diseases, and other rare indications. The different delivery models involved consist of on site clinical trials, decentralized clinical trials, and hybrid clinical trials, and these services are utilized by various end users including pharmaceutical and biotechnology companies, non profit and government organizations, academic and research institutes, and others.

Tariffs are influencing the rare disease contract research organization (CRO) market by raising the expenses associated with importing advanced laboratory instruments, genomic sequencing platforms, and specialized clinical trial technologies essential for rare disease studies. This is causing delays in clinical trial execution timelines and the development of data infrastructure, especially in regions that rely heavily on imported research equipment such as Asia-Pacific and Latin America. Service-driven segments including patient recruitment, data management, and clinical trial monitoring are experiencing the greatest impact due to their dependence on globally integrated digital and diagnostic supply chains. However, tariffs are also driving the localization of clinical research infrastructure, expansion of domestic CRO capabilities, and diversification of supplier ecosystems, which could ultimately enhance long-term resilience in rare disease clinical development systems.

The rare disease contract research organization (CRO) market research report is one of a series of new reports from The Business Research Company that provides rare disease contract research organization (CRO) market statistics, including rare disease contract research organization (CRO) industry global market size, regional shares, competitors with a rare disease contract research organization (CRO) market share, detailed rare disease contract research organization (CRO) market segments, market trends and opportunities, and any further data you may need to thrive in the rare disease contract research organization (CRO) industry. This rare disease contract research organization (CRO) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rare disease contract research organization (CRO) market size has grown strongly in recent years. It will grow from $2.07 billion in 2025 to $2.25 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to limited rare disease awareness restricting patient identification, fragmented clinical data systems limiting trial recruitment efficiency, high cost of orphan drug development reducing trial outsourcing scale, dependence on traditional site-based clinical research models, lack of standardized global rare disease regulatory frameworks.

The rare disease contract research organization (CRO) market size is expected to see strong growth in the next few years. It will grow to $3.16 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to advancement in genomic sequencing enabling early rare disease detection, increasing orphan drug approvals driving CRO outsourcing demand, expansion of precision medicine accelerating niche clinical research, rising adoption of decentralized trials improving global patient access, growing biotech investment in rare disease therapeutics. Major trends in the forecast period include adaptive patient-centric trial designs for ultra-rare disease cohorts, expansion of global rare disease patient registry ecosystems, increased adoption of decentralized and hybrid rare disease clinical trials, growth of specialized orphan drug regulatory consulting services, rising integration of real-world evidence in rare disease clinical validation.

The expansion of gene and cell therapy pipelines is expected to drive the growth of the rare disease contract research organization market going forward. Gene and cell therapies are advanced treatment approaches that modify genes or utilize engineered cells to address diseases at their underlying cause. Gene and cell therapies are expanding primarily due to the increasing prevalence of chronic and rare genetic disorders, as these therapies provide targeted and potentially curative interventions by addressing the root genetic or cellular abnormalities rather than only managing symptoms. Rare disease contract research organizations (CROs) support gene and cell therapy by designing and managing highly specialized clinical trials, enabling efficient identification and recruitment of patients with rare genetic conditions, ensuring regulatory compliance, and managing the complex data and logistics required for these precision-based therapies. For instance, in March 2024, according to IQVIA Holdings Inc., a US-based provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare industries, global spending on cell and gene therapies reached $5.9 billion in 2023, representing a 38% increase from 2022. Therefore, the expansion of gene and cell therapy pipelines is driving the growth of the rare disease contract research organization market.

The growth in research and development activities is expected to drive the growth of the rare disease contract research organization (CRO) market going forward. Research and development (R&D) activities refer to work conducted to generate new knowledge and apply it to develop or improve products, services, or technologies. Rising research and development activities are driven by the increasing need for continuous innovation to remain competitive in rapidly evolving markets, prompting companies to invest in advanced products and technologies that address evolving consumer demands and industry trends. Rare disease contract research organizations (CROs) support research and development by providing specialized expertise, infrastructure, and patient recruitment capabilities that help accelerate the design, execution, and management of complex rare disease clinical trials and drug development programs. For instance, in 2023, according to the Office for National Statistics, a UK-based government agency, the UK government's net spending on research and development (R&D) increased to £17.4 billion ($22.1 billion) in 2023, up from £16.1 billion ($20.45 billion) in 2022, marking an 8.2% rise. Therefore, the growth in research and development activities is driving the growth of the rare disease contract research organization market.

In May 2023, Worldwide Clinical Trials, a US-based full-service contract research organization specializing in rare diseases, entered into a partnership with Every Cure to accelerate the discovery and advancement of therapies for patients with rare diseases through drug repurposing and clinical research support. The collaboration is intended to enhance rare disease treatment development by applying drug repurposing approaches, utilizing AI-driven data analytics, and increasing the efficiency of clinical trials. Every Cure is a US-based nonprofit organization dedicated to identifying new therapeutic uses for existing drugs.

Major companies operating in the rare disease contract research organization (cro) market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings, ICON plc, SGS SA, Charles River Laboratories International Inc., Fortrea Holdings Inc., Medpace Holdings Inc., ALS Limited, PSI CRO AG, Ratos AB, Precision for Medicine Inc., Allucent, QPS Holdings LLC, Alira Health SAS, Rho Inc., Veristat LLC, Quanticate Ltd., Cromos Pharma LLC, Frontage Laboratories Inc., ProTrials Research Inc., PROMETRIKA LLC, Machaon Diagnostics Inc., Sofpromed GmbH

North America was the largest region in the rare disease contract research organization (CRO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease contract research organization (CRO) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rare disease contract research organization (CRO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rare disease contract research organization (CRO) market includes revenues earned by entities by providing services such as natural history studies, real-world evidence generation, biomarker research, and translational research support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rare Disease Contract Research Organization (CRO) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses rare disease contract research organization (cro) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rare disease contract research organization (cro) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rare disease contract research organization (cro) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Service Type: Drug Development Strategy; Clinical Trial Management; Patient Recruitment And Retention Services; Data Management And Biostatistics; Regulatory Affairs And Consulting; Pharmacovigilance Services; Medical Writing And Documentation; Decentralized Clinical Trial Services; Other Service Types
• 2) By Phase: Pre Clinical; Phase One; Phase Two; Phase Three; Phase Four
• 3) By Therapeutic Area: Oncology; Neurology; Cardiovascular Disorders; Metabolic Disorders; Genetic Disorders; Hematology; Immunology; Rare Infectious Diseases; Other Rare Indications
• 4) By Delivery Model: On Site Clinical Trials; Decentralized Clinical Trials; Hybrid Clinical Trials
• 5) By End User: Pharmaceutical And Biotechnology Companies; Non Profit And Government Organizations; Academic And Research Institutes; Other End Users
• Subsegments:
• 1) By Drug Development Strategy: Preclinical Development Planning; Clinical Development Planning; Target Identification And Validation; Portfolio Strategy Optimization
• 2) By Clinical Trial Management: Phase One Trial Management; Phase Two Trial Management; Phase Three Trial Management; Site Monitoring And Coordination
• 3) By Patient Recruitment And Retention Services: Patient Identification Services; Patient Enrollment Support; Patient Engagement Programs; Patient Retention Strategies
• 4) By Data Management And Biostatistics: Clinical Data Collection And Processing; Statistical Analysis And Modeling; Database Design And Management; Data Quality Assurance
• 5) By Regulatory Affairs And Consulting: Regulatory Strategy Development; Submission Preparation And Filing; Compliance And Audit Support; Regulatory Advisory Services
• 6) By Pharmacovigilance Services: Adverse Event Monitoring; Safety Data Analysis; Risk Management Planning; Signal Detection And Reporting
• 7) By Medical Writing And Documentation: Clinical Study Report Writing; Protocol Development Documentation; Regulatory Writing Services; Scientific Publication Writing
• 8) By Decentralized Clinical Trial Services: Remote Patient Monitoring; Virtual Trial Management; Home Healthcare Services; Digital Data Collection Solutions
• 9) By Other Service Types: Rare Disease Consulting Services; Genetic Research Support; Biomarker Development Services; Translational Research Services
• Companies Mentioned: Thermo Fisher Scientific Inc.; IQVIA Holdings Inc.; Laboratory Corporation of America Holdings; ICON plc; SGS SA; Charles River Laboratories International Inc.; Fortrea Holdings Inc.; Medpace Holdings Inc.; ALS Limited; PSI CRO AG; Ratos AB; Precision for Medicine Inc.; Allucent; QPS Holdings LLC; Alira Health SAS; Rho Inc.; Veristat LLC; Quanticate Ltd.; Cromos Pharma LLC; Frontage Laboratories Inc.; ProTrials Research Inc.; PROMETRIKA LLC; Machaon Diagnostics Inc.; Sofpromed GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Rare Disease Contract Research Organization (CRO) Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Rare Disease Contract Research Organization (CRO) Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Rare Disease Contract Research Organization (CRO) Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Rare Disease Contract Research Organization (CRO) Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Immersive Technologies (AR/VR/XR) & Digital Experiences
• 4.2. Major Trends
  • 4.2.1 Adaptive Patient Centric Trial Designs For Ultra Rare Disease Cohorts
  • 4.2.2 Expansion Of Global Rare Disease Patient Registry Ecosystems
  • 4.2.3 Increased Adoption Of Decentralized And Hybrid Rare Disease Clinical Trials
  • 4.2.4 Growth Of Specialized Orphan Drug Regulatory Consulting Services
  • 4.2.5 Rising Integration Of Real World Evidence In Rare Disease Clinical Validation

5. Rare Disease Contract Research Organization (CRO) Market Analysis Of End Use Industries

• 5.1 Pharmaceutical And Biotechnology Companies
• 5.2 Non Profit And Government Organizations
• 5.3 Academic And Research Institutes
• 5.4 Rare Disease Patient Advocacy Groups
• 5.5 Other End Users

6. Rare Disease Contract Research Organization (CRO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Rare Disease Contract Research Organization (CRO) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Rare Disease Contract Research Organization (CRO) PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Rare Disease Contract Research Organization (CRO) Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Rare Disease Contract Research Organization (CRO) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Rare Disease Contract Research Organization (CRO) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Rare Disease Contract Research Organization (CRO) Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Rare Disease Contract Research Organization (CRO) Market Segmentation

• 9.1. Global Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Drug Development Strategy, Clinical Trial Management, Patient Recruitment And Retention Services, Data Management And Biostatistics, Regulatory Affairs And Consulting, Pharmacovigilance Services, Medical Writing And Documentation, Decentralized Clinical Trial Services, Other Service Types
• 9.2. Global Rare Disease Contract Research Organization (CRO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pre Clinical, Phase One, Phase Two, Phase Three, Phase Four
• 9.3. Global Rare Disease Contract Research Organization (CRO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Neurology, Cardiovascular Disorders, Metabolic Disorders, Genetic Disorders, Hematology, Immunology, Rare Infectious Diseases, Other Rare Indications
• 9.4. Global Rare Disease Contract Research Organization (CRO) Market, Segmentation By Delivery Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• On Site Clinical Trials, Decentralized Clinical Trials, Hybrid Clinical Trials
• 9.5. Global Rare Disease Contract Research Organization (CRO) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical And Biotechnology Companies, Non Profit And Government Organizations, Academic And Research Institutes, Other End Users
• 9.6. Global Rare Disease Contract Research Organization (CRO) Market, Sub-Segmentation Of Drug Development Strategy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Preclinical Development Planning, Clinical Development Planning, Target Identification And Validation, Portfolio Strategy Optimization
• 9.7. Global Rare Disease Contract Research Organization (CRO) Market, Sub-Segmentation Of Clinical Trial Management, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Phase One Trial Management, Phase Two Trial Management, Phase Three Trial Management, Site Monitoring And Coordination
• 9.8. Global Rare Disease Contract Research Organization (CRO) Market, Sub-Segmentation Of Patient Recruitment And Retention Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Patient Identification Services, Patient Enrollment Support, Patient Engagement Programs, Patient Retention Strategies
• 9.9. Global Rare Disease Contract Research Organization (CRO) Market, Sub-Segmentation Of Data Management And Biostatistics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Clinical Data Collection And Processing, Statistical Analysis And Modeling, Database Design And Management, Data Quality Assurance
• 9.10. Global Rare Disease Contract Research Organization (CRO) Market, Sub-Segmentation Of Regulatory Affairs And Consulting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Regulatory Strategy Development, Submission Preparation And Filing, Compliance And Audit Support, Regulatory Advisory Services
• 9.11. Global Rare Disease Contract Research Organization (CRO) Market, Sub-Segmentation Of Pharmacovigilance Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Adverse Event Monitoring, Safety Data Analysis, Risk Management Planning, Signal Detection And Reporting
• 9.12. Global Rare Disease Contract Research Organization (CRO) Market, Sub-Segmentation Of Medical Writing And Documentation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Clinical Study Report Writing, Protocol Development Documentation, Regulatory Writing Services, Scientific Publication Writing
• 9.13. Global Rare Disease Contract Research Organization (CRO) Market, Sub-Segmentation Of Decentralized Clinical Trial Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Remote Patient Monitoring, Virtual Trial Management, Home Healthcare Services, Digital Data Collection Solutions
• 9.14. Global Rare Disease Contract Research Organization (CRO) Market, Sub-Segmentation Of Other Service Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Rare Disease Consulting Services, Genetic Research Support, Biomarker Development Services, Translational Research Services

10. Rare Disease Contract Research Organization (CRO) Market Regional And Country Analysis

• 10.1. Global Rare Disease Contract Research Organization (CRO) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Rare Disease Contract Research Organization (CRO) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Rare Disease Contract Research Organization (CRO) Market

• 11.1. Asia-Pacific Rare Disease Contract Research Organization (CRO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Rare Disease Contract Research Organization (CRO) Market

• 12.1. China Rare Disease Contract Research Organization (CRO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Rare Disease Contract Research Organization (CRO) Market

• 13.1. India Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Rare Disease Contract Research Organization (CRO) Market

• 14.1. Japan Rare Disease Contract Research Organization (CRO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Rare Disease Contract Research Organization (CRO) Market

• 15.1. Australia Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Rare Disease Contract Research Organization (CRO) Market

• 16.1. Indonesia Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Rare Disease Contract Research Organization (CRO) Market

• 17.1. South Korea Rare Disease Contract Research Organization (CRO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Rare Disease Contract Research Organization (CRO) Market

• 18.1. Taiwan Rare Disease Contract Research Organization (CRO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Rare Disease Contract Research Organization (CRO) Market

• 19.1. South East Asia Rare Disease Contract Research Organization (CRO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Rare Disease Contract Research Organization (CRO) Market

• 20.1. Western Europe Rare Disease Contract Research Organization (CRO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Rare Disease Contract Research Organization (CRO) Market

• 21.1. UK Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Rare Disease Contract Research Organization (CRO) Market

• 22.1. Germany Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Rare Disease Contract Research Organization (CRO) Market

• 23.1. France Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Rare Disease Contract Research Organization (CRO) Market

• 24.1. Italy Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Rare Disease Contract Research Organization (CRO) Market

• 25.1. Spain Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Rare Disease Contract Research Organization (CRO) Market

• 26.1. Eastern Europe Rare Disease Contract Research Organization (CRO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Rare Disease Contract Research Organization (CRO) Market

• 27.1. Russia Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Rare Disease Contract Research Organization (CRO) Market

• 28.1. North America Rare Disease Contract Research Organization (CRO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Rare Disease Contract Research Organization (CRO) Market

• 29.1. USA Rare Disease Contract Research Organization (CRO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Rare Disease Contract Research Organization (CRO) Market

• 30.1. Canada Rare Disease Contract Research Organization (CRO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Rare Disease Contract Research Organization (CRO) Market

• 31.1. South America Rare Disease Contract Research Organization (CRO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Rare Disease Contract Research Organization (CRO) Market

• 32.1. Brazil Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Rare Disease Contract Research Organization (CRO) Market

• 33.1. Middle East Rare Disease Contract Research Organization (CRO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Rare Disease Contract Research Organization (CRO) Market

• 34.1. Africa Rare Disease Contract Research Organization (CRO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Rare Disease Contract Research Organization (CRO) Market, Segmentation By Service Type, Segmentation By Phase, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Rare Disease Contract Research Organization (CRO) Market Regulatory and Investment Landscape

36. Rare Disease Contract Research Organization (CRO) Market Competitive Landscape And Company Profiles

• 36.1. Rare Disease Contract Research Organization (CRO) Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Rare Disease Contract Research Organization (CRO) Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Rare Disease Contract Research Organization (CRO) Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. ICON plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. SGS SA Overview, Products and Services, Strategy and Financial Analysis

37. Rare Disease Contract Research Organization (CRO) Market Other Major And Innovative Companies

• Charles River Laboratories International Inc., Fortrea Holdings Inc., Medpace Holdings Inc., ALS Limited, PSI CRO AG, Ratos AB, Precision for Medicine Inc., Allucent, QPS Holdings LLC, Alira Health SAS, Rho Inc., Veristat LLC, Quanticate Ltd., Cromos Pharma LLC, Frontage Laboratories Inc.

38. Global Rare Disease Contract Research Organization (CRO) Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Rare Disease Contract Research Organization (CRO) Market

41. Rare Disease Contract Research Organization (CRO) Market High Potential Countries, Segments and Strategies

• 41.1 Rare Disease Contract Research Organization (CRO) Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Rare Disease Contract Research Organization (CRO) Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Rare Disease Contract Research Organization (CRO) Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer